Skip to main content
SpringerLink
Log in

Switching TNF-α inhibitors causes AEs and symptoms related to underlying disease

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Assessment of Reported Adverse Events After Interchanging Between TNF-alpha Inhibitor Biosimilars in the WHO Pharmacovigilance Database BioDrugs : 6 Jun 2023. Available from: URL: https://doi.org/10.1007/s40259-023-00603-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Switching TNF-α inhibitors causes AEs and symptoms related to underlying disease. Reactions Weekly 1963, 12 (2023). https://doi.org/10.1007/s40278-023-42068-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-42068-x

Search

Navigation